{{Rsnum
|rsid=11902171
|Gene=ITGAV
|Chromosome=2
|position=186678500
|Orientation=plus
|GMAF=0.1653
|Gene_s=ITGAV
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 6.2 | 39.1 | 54.7
| HCB | 0.0 | 13.6 | 86.4
| JPT | 0.0 | 13.3 | 86.7
| YRI | 3.4 | 22.0 | 74.6
| ASW | 0.0 | 0.0 | 0.0
| CHB | 0.0 | 13.6 | 86.4
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=22271436
|Title=Single-nucleotide polymorphisms of integrins are associated with the risk and lymph node metastasis of oral squamous cell carcinoma
}}

{{PMID Auto
|PMID=20926544
|Title=Allele polymorphisms of tumor integrins correlate with peritoneal carcinosis capability of gastric cancer cells in radically resected patients.
}}

{{PMID Auto
|PMID=23065910
|Title=Genetic variants in the integrin gene predicted microRNA-binding sites were associated with the risk of prostate cancer
}}

{{PMID Auto
|PMID=24769516
|Title=Polymorphisms of microRNA-Binding Sites in Integrin Genes Are Associated with Oral Squamous Cell Carcinoma Susceptibility and Progression
}}
{{on chip | HumanOmni1Quad}}